Evaluating products.
How do I choose an NAC product — and what does the honest shelf look like?
Shelf order follows the trial evidence and the safety line together: NOW's 600 mg immediate-release leads as the studied-dose format (the COPD-trial dose, the same product our lungs and liver pages feature), Jarrow's bilayer time-release smooths the half-life at the same dose, and the liposomal glutathione closes as the delivery-technology alternative with its honest caveat (the trials are NAC's). All three work the same chemistry; the dose and the physician conversation are the decisions. The products below are educational examples — not medical recommendations.
NOW N-Acetyl Cysteine 600 mg
by NOW Foods · N-Acetyl Cysteine (Free Form)
Score
The studied dose: the COPD/chronic-bronchitis trials used 600 mg 1–2× daily — the format that matches the evidence. The sulfur smell is the molecule's identity, not a defect. 🚨 NAC can potentiate nitroglycerin (the documented interaction — anyone on heart medication needs physician involvement). GI upset is the common side effect. Not for anyone with a sulfite/nitroglycerin sensitivity without medical guidance.
Runner-ups
Jarrow Formulas NAC Sustain
by Jarrow Formulas · NAC (Bilayer Time-Release)
Liposomal Glutathione (The End Product)
by Various (liposomal) · Reduced Glutathione (Liposomal)